Literature DB >> 15712044

[Lymph node metastasis of glottic laryngeal carcinoma].

F Waldfahrer1, B Hauptmann, H Iro.   

Abstract

UNLABELLED: The incidence of lymph node metastases in glottic cancer is assumed to be lower than in other head and neck cancers. In a retrospective study this statement was investigated.
MATERIAL AND METHODS: This analysis was based on 910 consecutive patients with glottic carcinoma treated between 1970 and 1990 by means of surgery with special interest on regional lymph node metastases.
RESULTS: 8.6 % patients had clinically positive necks (N+) and 5.9 % pathohistologically positive necks (pN+). The incidence of lymph node metastases showed correlation with pT category and vocal cord mobility. Lymph node metastases were found in 5 % of pT2, in 18 % of pT3 and in 32 % of pT4 tumors. Only one patient with pT1 cancer had metastatic lymph node involvement. The incidence of occult lymph node metastases was 18 %. Lymph node involvement, extracapsular spread and lymphangiosis carcinomatosa proved to be relevant prognostic factors. The 5 year recurrent free survival rate was 86.7 % for the whole group, 81.6 % for patients with negative nodes (pN0), and 61.8 % for patients with pN+ nodes (p < 0.001 according to logrank test).
CONCLUSIONS: Clinical lymph node staging plays an important prognostic role in the staging procedure also in glottic carcinoma. At least in T3 carcinomas, elective treatment of the cervical lymph nodes seems to be necessary. T2 carcinomas with impaired cord mobility have a significant higher risk for metastatic spread; therefore neck dissection should be discussed also in these cases.

Entities:  

Mesh:

Year:  2005        PMID: 15712044     DOI: 10.1055/s-2004-826075

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  5 in total

1.  Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Authors:  Abdallah S R Mohamed; Blaine D Smith; Joshua B Smith; Parag Sevak; Jessica S Malek; Aasheesh Kanwar; Theodora Browne; G Brandon Gunn; Adam S Garden; Steven J Frank; William H Morrison; Jack Phan; Mark Zafereo; Heath Skinner; Stephen Y Lai; Katherine A Hutcheson; Jan S Lewin; Amy E Hessel; Apurva A Thekdi; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Laryngoscope       Date:  2019-02-12       Impact factor: 3.325

2.  Patterns of Cervical Lymph Node Metastasis in Locally Advanced Supraglottic Squamous Cell Carcinoma: Implications for Neck CTV Delineation.

Authors:  Yi Xu; Ye Zhang; Zhengang Xu; Shaoyan Liu; Guozhen Xu; Li Gao; Jingwei Luo; Xiaodong Huang; Kai Wang; Yuan Qu; Shiping Zhang; Qingfeng Liu; Runye Wu; Xuesong Chen; Junlin Yi
Journal:  Front Oncol       Date:  2020-08-27       Impact factor: 6.244

3.  Surgical vs Nonsurgical Treatment Modalities for T3 Glottic Squamous Cell Carcinoma.

Authors:  Maha Al-Gilani; S Andrew Skillington; Dorina Kallogjeri; Bruce Haughey; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-10-01       Impact factor: 6.223

Review 4.  Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.

Authors:  Hilke Vorwerk; Clemens F Hess
Journal:  Radiat Oncol       Date:  2011-08-19       Impact factor: 3.481

5.  Lymph Nodes Dissection in Elderly Patients with T3-T4 Laryngeal Cancer.

Authors:  Yafeng Pan; Xuye Zhao; Dean Zhao; Junhua Liu
Journal:  Clin Interv Aging       Date:  2020-12-08       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.